Regencell Bioscience Limited (RGC)
28.89
1.64 (6.02%)
Apr 17, 2025, 3:30 PM - Market open
6.02% (1D)
| Bid | 28.55 |
| Market Cap | 375.94M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.24M |
| EPS (ttm) | -0.33 |
| PE Ratio (ttm) | -87.55 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 29.19 |
| Volume | 17,527 |
| Avg. Volume (20D) | 686,057 |
| Open | 28.37 |
| Previous Close | 27.25 |
| Day's Range | 27.05 - 29.50 |
| 52-Week Range | 3.03 - 69.00 |
| Beta | -4.30 |
About RGC
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong....
Full Company Profile5 months ago
+31.18%
Regencell Bioscience shares are trading higher. Th...
Unlock content with
Pro Subscription
